Mirum's LIVMARLI Now FDA Approved in Tablet Formulation
1. LIVMARLI gains FDA approval for tablet formulation, enhancing treatment options. 2. This approval may drive sales and market share for MIRM.
FAQ
Why Bullish?
FDA approval usually boosts company stock prices. Historical precedents for drug approvals show positive price movements.
How important is it?
FDA approval can significantly impact revenue growth, attracting investor interest and improving market perception.
Why Short Term?
Immediate sales boost anticipated from new tablet formulation; likely quick market reactions.